BusulfanMelphalanAntineoplastic Agents, AlkylatingTransplantation ConditioningChemotherapy, Cancer, Regional PerfusionMyeloablative AgonistsTransplantation, AutologousMultiple MyelomaCyclophosphamideBone Marrow TransplantationAntineoplastic Combined Chemotherapy ProtocolsAlkylating AgentsToxicity TestsTransplantation, HomologousVidarabineCombined Modality TherapyWhole-Body IrradiationHepatic Veno-Occlusive DiseaseThiotepaDose-Response Relationship, DrugGraft vs Host DiseaseTreatment OutcomeAntineoplastic AgentsDrug Administration ScheduleDisease-Free SurvivalSurvival AnalysisCarmustineDrug EvaluationEtoposideImmunosuppressive AgentsToxicity Tests, AcuteHematopoietic Stem Cell TransplantationHematologic NeoplasmsGraft SurvivalPrednisoneAmyloidosisStem Cell TransplantationTransplantation ChimeraPeripheral Blood Stem Cell TransplantationSurvival RateAdministration, OralMisonidazoleButhionine SulfoximineThalidomideTime FactorsVincristineInfusions, IntravenousMethionine SulfoximineMyelodysplastic SyndromesLeukemiaDrug ResistanceBoronic AcidsPyrazinesDrug MonitoringDoxorubicinHematologic DiseasesLeukemia, Myeloid, AcuteGlutathione TransferaseCell SurvivalMetabolic Clearance RateCytarabineBone MarrowArea Under CurveAntilymphocyte SerumLeukemia, MyeloidFollow-Up StudiesDrug SynergismLeukemia, Myelogenous, Chronic, BCR-ABL PositiveGlutathioneSulfonic AcidsNeoplasmsChlorambucilRemission InductionBone Marrow PurgingBlood Cell CountSalvage TherapyCisplatinSpermatogoniaActuarial AnalysisHistocompatibilityInjections, IntravenousMelanomaRetrospective StudiesOogoniaMethotrexateThrombocytopeniaStomatitisLeukocyte CountPharmaceutical SolutionsLomustineDrug Screening Assays, AntitumorLymphoma, Non-HodgkinExtremitiesDexamethasoneNitrogen Mustard CompoundsSemustineSeminiferous TubulesRats, NudeDrug Therapy, Combination